Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$0.66 USD
-0.08 (-10.97%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.72 +0.06 (9.42%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Plus Therapeutics, Inc. has a market cap of $44.71M, which represents its share price of $0.74 multiplied by its outstanding shares number of 60.49M. As a small-cap company, PSTV's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PSTV 0.66 -0.08(-10.97%)
Will PSTV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PSTV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PSTV
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates
Plus (PSTV) Upgraded to Buy: Here's Why
PSTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates
The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates
Other News for PSTV
12 Health Care Stocks Moving In Thursday's Intraday Session
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025
Plus Therapeutics says CNSide CSF platform will be available for Texas in August
Biotech Continues This Week's Momentum With Another Key Announcement